Shanghai, China

Xiaoxing Du

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 12.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Innovations of Xiaoxing Du in Pharmaceutical Research

Introduction

Xiaoxing Du is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that enhance the production of erythropoietin. With a total of four patents to his name, Du's work has the potential to impact the treatment of conditions such as anemia.

Latest Patents

Du's latest patents focus on inhibitors of HIF prolyl hydroxylase. The first patent describes compounds that inhibit HIF prolyl hydroxylase, which can enhance the endogenous production of erythropoietin. This invention is particularly relevant for treating conditions associated with reduced endogenous production of erythropoietin, such as anemia. The second patent reiterates similar findings, emphasizing the importance of these compounds and their pharmaceutical compositions.

Career Highlights

Throughout his career, Xiaoxing Du has worked with notable companies in the pharmaceutical industry. He has been associated with Merck Sharp & Dohme Corporation and MSD R&D Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Du has collaborated with several professionals in his field, including Jiaqiang Cai and Alejandro Crespo. These collaborations have likely enriched his research and contributed to the advancements in his patented inventions.

Conclusion

Xiaoxing Du's innovative work in the pharmaceutical sector, particularly in the development of erythropoietin production enhancers, showcases his significant contributions to medical science. His patents reflect a commitment to addressing critical health issues such as anemia.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…